logo

Implantable Drug Delivery Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Implantable Drug Delivery Devices Market is Segmented by Product, Technology (Biodegradable Implants and Non-biodegradable Implants), Application, and Geography

Home Industry Reports Healthcare Implantable Drug Delivery Devices Market - Growth, Trends, COVID-19 Impact, and ...

Market Snapshot

Implantable Drug Delivery-1
Study Period:

2018 - 2026

Base Year:

2020

Fastest Growing Market:

Asia Pacific

Largest Market:

North America

CAGR:

6.5 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The implantable drug delivery devices market is expected to witness robust growth due to the increasing geriatric population, rise in the number of cancer cases, a growing number of cardiology, ophthalmology abnormalities and the rise in technological advancements. Furthermore with the increase in the burden of chronic diseases the large patient population increases the number of surgeries and hence drives the implantable drug delivery devices market. In addition, the growing preference for drug-device combination products owing to higher efficacy also serves as a key contributing factor.

However, the high cost of devices and surgery costs, low rate of adoption are the few restraining factors of the growth of implantable drug delivery devices market.

Scope of the Report

As per the scope, implantable drug delivery devices are the devices that are used to administer drugs and fluids to the body, without the repeated insertion of needles. Drug delivery is the process of administering a pharmaceutical substance, to achieve therapeutic effects, in humans or animals. Over the past decade, there has been increasing convergence between drug therapies and implantable devices, which include devices such as osmotic pumps and implantable rods, which deliver drugs to specific targeted areas (anticancer agents, hormones, and vaccines).

By Product Type
Drug Infusion Pumps
Intraocular Drug Delivery Devices
Contraceptive Drug Delivery Devices
Stents
Others
By Technology
Biodegradable Implants
Non-biodegradable Implants
By Application
Oncology
Cardiovascular
Autoimmune Diseases
Obstetrics and Gynecology
Other Applications
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Drug Infusion Pumps Segment is Expected to Hold a Significant Market Share

Infusion pumps are devices that are used to deliver fluids into a patient’s body, in a controlled manner. They are capable of supplying medications such as insulin or other hormones, antibiotics, chemotherapy drugs, and pain relievers. Infusion pumps play an important role in delivering accurate medications in chemotherapy, for diabetics, etc., for the corresponding diseases.

The rising number of diabetes cases and increasing investments in diabetes care and management have helped in the adoption of insulin infusion pumps. Technological advancements, coupled with increasing R&D initiatives on gastrointestinal disorders, cancer, neurological problems, and AIDS, are providing lucrative opportunities for infusion pumps in the market. According to the FDA, in 2017, Baxter’s Sigma Spectrum Infusion pump has been the number one infusion pump in drug library compliance. Sigma Spectrum has a user interface that provides top-quality patient safety margins and has the ability to integrate with leading electronic medical record systems.

Chronic diseases.png

To understand key trends, Download Sample Report

North America Dominates the Implantable Drug Delivery Devices Market

In North America, the medical device industry is a highly regulated sector of the economy. There are several studies that suggest that the US manufacturers of implantable devices can maintain high prices, in part due to structural barriers such as costly regulatory approval processes and patent protections. Therefore, manufacturers face problems in launching new products in the United States. 

Hospitals are the primary purchasers of most high-cost implantable devices in the United States, but they have limited bargaining power to negotiate for lower prices. There are millions of Americans being implanted with implantable devices such as artificial hips or cardiac pacemakers, in their bodies. Experts have also estimated that 7.2 million Americans are living with joint implants. However, due to the aging population and the increasing prevalence of chronic conditions, the number of patients adopting implantable devices continues to grow exponentially. During the past year, in the United States, there have been many advancements in technology and medical innovation, which have expanded the types of implantable devices, to include artificial hearts and deep-brain stimulators to control epilepsy.

Implantable Drug Delivery - Geo

To understand geography trends, Download Sample Report

Competitive Landscape

The market players are found focusing on new product launches, minimizing the price of the tests in order to gain maximum traction in the global market. Furthermore, market players are concentrating on various growth strategies such as collaborations, acquisitions, partnerships to enhance their market presence. In addition, market leaders are highly focused on delivering economic value and cater to unmet needs.

Implantable Drug Delivery-4

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Demand for Minimally Invasive Procedures

      2. 4.2.2 Emergence of Novel Products

      3. 4.2.3 Increasing Prevalence of Chronic Diseases

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost of Devices

      2. 4.3.2 Stringent Regulatory Requirements

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product Type

      1. 5.1.1 Drug Infusion Pumps

      2. 5.1.2 Intraocular Drug Delivery Devices

      3. 5.1.3 Contraceptive Drug Delivery Devices

      4. 5.1.4 Stents

      5. 5.1.5 Others

    2. 5.2 By Technology

      1. 5.2.1 Biodegradable Implants

      2. 5.2.2 Non-biodegradable Implants

    3. 5.3 By Application

      1. 5.3.1 Oncology

      2. 5.3.2 Cardiovascular

      3. 5.3.3 Autoimmune Diseases

      4. 5.3.4 Obstetrics and Gynecology

      5. 5.3.5 Other Applications

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Allergan PLC

      2. 6.1.2 Boston Scientific Corporation

      3. 6.1.3 Bausch and Lomb Inc.

      4. 6.1.4 Medtronic PLC

      5. 6.1.5 Alcon Inc.

      6. 6.1.6 Teleflex Incorporated

      7. 6.1.7 DSM Biomedical

      8. 6.1.8 Delpor Inc.

      9. 6.1.9 3M Company

      2. *List Not Exhaustive

  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Implantable Drug Delivery Devices Market market is studied from 2018 - 2026.

The Implantable Drug Delivery Devices Market is growing at a CAGR of 6.5% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

  • DSM Biomedical
  • Delpor Inc.
  • Medtronic
  • Teleflex Incorporated
  • 3M Company

Are the major companies operating in Implantable Drug Delivery Devices Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!